Jump to content

Template:Side effects of combined androgen blockade with nilutamide and a GnRH agonist

From Wikipedia, the free encyclopedia
Side effects of combined androgen blockade with nilutamide and a GnRH agonist
Class Side effect Nilutamide 150 mg/day +
leuprorelin (n = 209) (%)a,b
Placebo + leupro-
relin
(n = 202) (%)a,b
Body as a whole Pain 26.8 27.7
Headache 13.9 10.4
Asthenia 19.1 20.8
Back pain 11.5 16.8
Abdominal pain 10.0 5.4
Chest pain 7.2 4.5
Flu syndrome 7.2 3.0
Fever 5.3 6.4
Cardiovascular system Hypertension 9.1 9.9
Digestive system Nausea 23.9 8.4
Constipation 19.6 16.8
Anorexia 11.0 6.4
Dyspepsia 6.7 4.5
Vomiting 5.7 4.0
Endocrine system Hot flashes 66.5 59.4
Erectile dysfunction 11.0 12.9
Decreased libido 11.0 4.5
Hemic and lymphatic system Anemia 7.2 6.4
Metabolic and nutritional system Increased aspartate transaminase 12.9 13.9
Peripheral edema 12.4 17.3
Increased alanine transaminase 9.1 8.9
Musculoskeletal system Bone pain 6.2 5.0
Nervous system Insomnia 16.3 15.8
Dizziness 10.0 11.4
Depression 8.6 7.4
Hypesthesia 5.3 2.0
Respiratory system Dyspnea 10.5 7.4
Upper respiratory infection 8.1 10.9
Pneumonia 5.3 3.5
Skin and appendages Sweating 6.2 3.0
Decreased body hair 5.7 0.5
Dry skin 5.3 2.5
Rash 5.3 4.0
Special senses Impaired adaptation to darkness 56.9 5.4
Chromatopsia 8.6 0.0
Impaired adaptation to light 7.7 1.0
Abnormal vision 6.2 4.5
Urogenital system Testicular atrophy 16.3 12.4
Gynecomastia 10.5 11.9
Urinary tract infection 8.6 21.3
Hematuria 8.1 7.9
Urinary tract disorder 7.2 10.4
Nocturia 6.7 6.4
Overall 99.5 98.5
Footnotes: a = Phase III studies of combined androgen blockade (nilutamide + GnRH agonist) in men with advanced prostate cancer. b = Incidence ≥5% regardless of causality. Sources: [1]